D-0385-2026 Class II Ongoing
FDA drug recall D-0385-2026 was initiated by HTO Nevada Inc. Dba Kirkman on Feb 18, 2026 and is designated Class II. Reason for recall: Stability Data Does Not Support Expiry Date. The recall status is ongoing. Affected quantity: 27,380 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 11, 2026
- Initiation Date
- Feb 18, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 27,380 bottles.
Product description
FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-016.
Reason for recall
Stability Data Does Not Support Expiry Date.
Distribution pattern
Nationwide within the U.S
Code information
Lot #: 839CP-0016, Exp. Date 03/31/2026; 839CP-0017, Exp. Date 06/30/2026; 839CP-0018, Exp. Date 08/31/2026; 839CP-0019, Exp. Date 10/31/2026; 839CP-0020, Exp. Date 03/31/2027; 839CP-0021, Exp. Date 07/31/2027; 839CP-0022, Exp.Date 11/30/2027; 839CP-0023, Exp. Date 02/29/2028; 839CP-0024, Exp. Date 07/31/2028.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0385-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026